These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
32. Efficacy and safety of basiliximab with a tacrolimus-based regimen in liver transplant recipients. Marino IR; Doria C; Scott VL; Foglieni CS; Lauro A; Piazza T; Cintorino D; Gruttadauria S Transplantation; 2004 Sep; 78(6):886-91. PubMed ID: 15385809 [TBL] [Abstract][Full Text] [Related]
33. Risk and benefit of antibody induction therapy in combination with tacrolimus immunosuppression after liver transplantation. Klupp J; Bechstein WO; Pratschke J; Tullius SG; Gebhard A; Lobeck H; Langrehr JM; Neuhaus R; Neuhaus P Transplant Proc; 1998 Jun; 30(4):1443-4. PubMed ID: 9636585 [No Abstract] [Full Text] [Related]
34. Lower tacrolimus trough levels in the late period after living donor liver transplantation contribute to improvements in long-term clinical outcomes. Geng L; Wang LD; Huang JJ; Shen T; Wang ZY; Lin BY; Ye YF; Zheng SS Hepatobiliary Pancreat Dis Int; 2018 Jun; 17(3):204-209. PubMed ID: 29807766 [TBL] [Abstract][Full Text] [Related]
35. Basiliximab in a triple-drug regimen with tacrolimus and steroids in liver transplantation. Gruttadauria S; Vasta F; Mandalà L; Cintorino D; Piazza T; Spada M; Verzaro R; Gridelli B Transplant Proc; 2005; 37(6):2611-3. PubMed ID: 16182762 [TBL] [Abstract][Full Text] [Related]
36. Reasons for long-term use of steroid in primary adult liver transplantation under tacrolimus. Jain A; Kashyap R; Marsh W; Rohal S; Khanna A; Fung JJ Transplantation; 2001 Apr; 71(8):1102-6. PubMed ID: 11374410 [TBL] [Abstract][Full Text] [Related]
37. Results of pancreas transplantation after steroid withdrawal under tacrolimus immunosuppression. Jordan ML; Chakrabarti P; Luke P; Shapiro R; Vivas CA; Scantlebury VP; Fung JJ; Starzl TE; Corry RJ Transplantation; 2000 Jan; 69(2):265-71. PubMed ID: 10670637 [TBL] [Abstract][Full Text] [Related]